Department of Physical Medicine and Rehabilitation, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Department of Rehabilitation Sciences, University of Maryland Baltimore, Baltimore, Maryland, USA.
Phys Ther. 2021 Feb 4;101(2). doi: 10.1093/ptj/pzaa203.
For people with ataxia, there are validated outcome measures to address body function and structure (BFS) impairments and participation; however, no outcome measure exists for upper extremity (UE) activity level in this population. The purpose of this study was to determine whether the action research arm test (ARAT), a measure of UE activity validated for other neurological conditions, might be a useful outcome measure for capturing UE activity limitations in ataxia.
A total of 22 participants with ataxia were evaluated to assess construct validity of the ARAT; 19 of the participants were included in the interrater reliability assessment. Participants received a neurologic examination and completed a battery of outcome measures, including the ARAT. ARAT performance was video recorded and scored by 4 additional raters.
For construct validity, Spearman rho showed a significant moderate relationship between the ARAT and BSF outcome measures. A small, nonsignificant relationship was noted for the ARAT and the participation measure. For interrater reliability, Spearman rho showed a large, significant relationship among all raters for the ARAT (range = .87-.94). High reliability was demonstrated using the intraclass correlation coefficient ([2,1] = .97).
The ARAT is moderately correlated with ataxia BFS outcome measures, but not with participation scores. The ARAT is a measure of UE activity, which is different from BFS and participation outcome measures. The ARAT was identified to have strong interrater reliability among raters with varying amounts of experience administering the ARAT. Thus, for the ataxic population, the ARAT may be useful for assessing UE activity limitations.
Ataxia can negatively affect reaching tasks; therefore, it is important to assess UE activity level in people with ataxia. Until this study, no outcome measure had been identified for this purpose.
People with ataxia may have difficulty with daily tasks that require reaching. The ARAT is an outcome measure that clinicians can use to assess UE activity limitations to help design a treatment program.
对于共济失调患者,有经过验证的结局测量方法可用于评估身体功能和结构(BFS)损伤和参与度;然而,针对该人群,尚没有用于上肢(UE)活动水平的结局测量方法。本研究旨在确定针对其他神经疾病验证的 UE 活动测量方法——行动研究臂测试(ARAT),是否可能成为评估共济失调患者 UE 活动受限的有用结局测量方法。
共有 22 名共济失调患者接受评估,以评估 ARAT 的结构效度;其中 19 名参与者纳入了评分者间信度评估。参与者接受了神经系统检查并完成了一系列结局测量,包括 ARAT。ARAT 表现通过 4 名额外的评分者进行视频记录和评分。
在结构效度方面,Spearman rho 显示 ARAT 与 BFS 结局测量之间存在显著中度相关性。ARAT 与参与度测量之间的相关性较小,无统计学意义。对于评分者间信度,Spearman rho 显示所有评分者的 ARAT 之间具有较大的显著相关性(范围为.87-.94)。使用组内相关系数([2,1] =.97)显示了高度可靠性。
ARAT 与共济失调 BFS 结局测量中度相关,但与参与评分无关。ARAT 是一种 UE 活动测量方法,与 BFS 和参与度结局测量不同。ARAT 被确定为在具有不同 ARAT 施测经验的评分者之间具有很强的评分者间信度。因此,对于共济失调患者,ARAT 可能有助于评估 UE 活动受限。
共济失调可使患者在完成需要伸手的日常任务时出现困难;因此,评估共济失调患者的 UE 活动水平非常重要。在此研究之前,尚无针对该目的的结局测量方法。
共济失调患者可能在完成需要伸手的日常任务时存在困难。ARAT 是一种临床医生可以用来评估 UE 活动受限的结局测量方法,有助于设计治疗方案。